P PRIMESTOCKFINDER.COM

COH Shares Cochlear Limited

WATCH ASX · ASX
$139.82 -1.41% Prices as of close 2026-10-26

Global hearing-device leadership, resilient demand, and sector rotation into high-quality franchises support further upside.

Future value: $136.34 (-2.49%) · 6-12 months · analyst consensus

Signal breakdown

  • ▸Positive sector momentum and institutional preference for quality healthcare
  • ▸Above 50-day MA (+2.46%)
  • ▾Trading above its price target — limited upside

Is COH a buy right now?

Trend: COH is trading above the 50-day average (+3.91%), RSI 15 — oversold territory, with a 3-month return of +16.06%.

Valuation & quality: Cochlear Limited trades on a trailing P/E of 60.3, forward P/E 25.0, PEG 3.08, price-to-book 5.33; fundamentals show net margin 6.3%, return on equity 8.0%, revenue growth 0.8% year on year.

Analyst consensus: 16 analysts have a mean 12-month price target of A$136.34 (-2.5% vs the last close; range A$110.00 – A$165.00), consensus rating “hold”.

Income: trailing dividend yield 1.77%.

Our screen: WATCH (score 0) — Global hearing-device leadership, resilient demand, and sector rotation into high-quality franchises support further upside.

Computed from end-of-day data; not personal advice.

12-month price chart

256.9 90.0 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-26 (AUD). Range 90.0 – 256.9.

Monthly returns

Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
-12.00%-46.30%+6.90%+21.10%-1.50%+11.70%+4.20%+1.60%

Fundamentals

Market cap
$9.27B
P/E (ttm)
60.3
Forward P/E
25.0
EPS (ttm)
$2.35
Price / book
5.33
PEG
3.08
Beta
0.24
Net margin
6.3%
ROE
8.0%
Revenue growth
0.8%
Revenue (ttm)
$2.35B
Free cash flow
$313.6M
Debt / equity
12%
Dividend yield
1.77%
52-wk range
$88.74 – $296.50
Volume
446,725
Avg volume (3m)
583,135

Analyst price target

Mean target
$136.34
Low
$110.00
High
$165.00
Analysts
16
Consensus
HOLD

Technical signals

RSI (14)
15.2
vs 50-day MA
+3.91%
1-mo return
-2.28%
3-mo return
+16.06%
Volume z-score
0.51

About Cochlear Limited

Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers cochlear implant systems; replacement sound processors, accessories, and other services; bone conduction systems and replacement sound processors; and recipient support tools.

Sector: Healthcare · Industry: Medical Devices · Australia · 5,400 employees · Website

Related Health Care picks

CSL.AXCSL LimitedPME.AXPro Medicus LimitedRMD.AXResMed Inc.FPH.AXFisher & Paykel HealthRHC.AXRamsay Health Care LimNAN.AXNanosonics LimitedSIG.AXSigma Healthcare LimitEBO.AXEBOS Group Limited

Browse: all ASX stocks · Health Care picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.